endocrine/exocrine glands
• 13% of mice exhibit fibroadenoma in the mammary gland
|
neoplasm
• 13% of mice exhibit fibroadenoma in the mammary gland
|
• mice exhibit osseous metaplasia in the lung, brain, kidney, and nasal mucosa
|
• 6% of mice develop neurofibroma
|
• in 56% in mice
|
• 6% of mice develop anaplastic carcinoma in the kidney
|
• 13% of mice develop carcino-sarcoma in the mammary gland
|
• 6% of mice develop neurofibrosarcoma with 2 of 7 metastasizing to the liver
|
• in 44% of mice
|
• 6% of mice develop mesothelioma
|
• 50% of mice develop osteoma
|
integument
• 13% of mice exhibit fibroadenoma in the mammary gland
|
skeleton
• 6% of mice exhibit odontoblastic hyperplasia
|
• in 44% of mice
|
• 50% of mice develop osteoma
|
• osteoblastic hyperplasia in 44% of mice
|
renal/urinary system
• 6% of mice develop anaplastic carcinoma in the kidney
|
• 38% of mice exhibit renal tubular cell hyperplasia
|
respiratory system
• in 56% in mice
|
nervous system
N |
• mice exhibit normal Schwann cell proliferation
|
• 6% of mice develop neurofibroma
|
• 6% of mice develop neurofibrosarcoma with 2 of 7 metastasizing to the liver
|
craniofacial
• 6% of mice exhibit odontoblastic hyperplasia
|
growth/size/body
• 6% of mice exhibit odontoblastic hyperplasia
|